NSD2 and neoplasm: Overall, these results suggest that changes in the immune circuitry following WHSC1 inhibition in vivo were driven by a rewiring of the signaling from macrophage subsets and DCs, to ultimately elicit anti-tumor effects from T, NK, and B cells.